Prevalence & Risk Factors of Non-Alcohol Fatty Liver Disease (NAFLD) in Urban & Rural Communities of Pakistan
DOI:
https://doi.org/10.61919/jhrr.v5i11.1889Keywords:
NAFLD, Pakistan, Prevalence, Obesity, Diabetes, UltrasoundAbstract
Background: The rising condition of non-alcoholic fatty liver disease (NAFLD) has been widely observed in South Asia due to the increasing trends of urbanization and lifestyle factors because of metabolic disturbances. Objective: To identify the prevalence of NAFLD risk factors, along with metabolic and sociodemographic and lifestyle factors, in the adult population of Pakistan’s urban and rural settings. Methods: This study was carried out using a cross-sectional approach involving 108 adults who attended the general hospital of Sialkot in Pakistan. The study used a structured questionnaire to gather information regarding the sociodemographic factors of the participants. Anthropometric measurements were also done. NAFLD was also identified using the criterion of the absence of severe alcohol consumption along with the absence of chronic liver diseases alongside the criterion of the detection of hepatic steatosis through ultrasonography. Statistical computation was carried out using the software package SPSS version 25. Results: The prevalence of NAFLD was 48.1%. The prevalence of NAFLD was higher in the urban group than the rural group (56.3% vs. 36.4%; p=0.042). In the NAFLD group, there were higher levels of BMI, waist measurement, ALT levels, AST levels, and triglyceride levels, along with lower levels of HDL. Conclusion: NAFLD has been found to be prevalent within this dual non-rural community of Pakistani patients and has been found to be strongly linked to obesity, diabetes, and a sedentary lifestyle.
Downloads
References
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016.
Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, UK, and USA. J Hepatol. 2018.
European Association for the Study of the Liver (EASL). Clinical Practice Guidelines: NAFLD. J Hepatol. 2016.
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction–associated fatty liver disease. Lancet Gastroenterol Hepatol. 2020.
Rinella ME, Lazarus J. Emerging consensus definition for MASLD. Hepatology. 2023.
Fan JG, Kim SU, Wong VW. New trends on MASLD in Asia. Hepatol Int. 2022.
Asia-Pacific Working Party on NAFLD. Guidelines for diagnosis and management. Hepatol Int.
Abbas Z, Zaheer A. Non-alcoholic fatty liver disease: A real threat in Pakistan. JPMA. 2020.
Kamal S. NAFLD—An Emerging Challenge. Nat J Health Sci. 2023.
Rizwana Abdul Ghani et al. Identification of metabolic phenotypes… Pak J Med Sci. 2017.
Bano U et al. Evaluation of risk factors of NAFLD in Rawalpindi. 2011.
Shah A et al. Prevalence of NAFLD and NASH in Peshawar Cantonment. Pak J Pharm Sci. 2018.
Butt A et al. Prevalence and risk factors of NAFLD in Karachi. 2020.
Hussain Z et al. Assessment of risk factors of NAFLD. Pak J Health Sci. 2023.
Mahmood H et al. Risk factors associated with NAFLD. Pak J Med Health Sci. 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sidra Afzal, Faiza Amjad, Muhammad Laeeq, Laj Khan

This work is licensed under a Creative Commons Attribution 4.0 International License.
Public Licensing Terms
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license:
- You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, including commercial use.
- Attribution must be given to the original author(s) and source in a manner that is reasonable and does not imply endorsement.
- No additional restrictions may be applied that conflict with the terms of this license.
For more details, visit: https://creativecommons.org/licenses/by/4.0/.

